Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporatedverified

0QZU.L

Price:

$432.56

Market Cap:

$111.46B

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial; VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases which is in Phase 2 clin...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2014-11-10

Stock Exchange

LSE

Ticker

0QZU.L

The PE Ratio as of May 2025 (TTM) for Vertex Pharmaceuticals Incorporated (0QZU.L) is 45.65

According to Vertex Pharmaceuticals Incorporated’s latest financial reports and current stock price. The company's current PE Ratio is 45.65. This represents a change of 88.63% compared to the average of 24.20 of the last 4 quarters.

Vertex Pharmaceuticals Incorporated (0QZU.L) Historical PE Ratio (quarterly & annually)

How has 0QZU.L PE Ratio performed in the past?

The mean historical PE Ratio of Vertex Pharmaceuticals Incorporated over the last ten years is -10.06. The current 45.65 PE Ratio has changed -45471.80% with respect to the historical average. Over the past ten years (40 quarters), 0QZU.L's PE Ratio was at its highest in in the June 2017 quarter at 443.13. The PE Ratio was at its lowest in in the September 2016 quarter at -126.50.

Quarterly (TTM)
Annual

Average

-10.06

Median

22.45

Minimum

-193.61

Maximum

141.54

Vertex Pharmaceuticals Incorporated (0QZU.L) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Vertex Pharmaceuticals Incorporated PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 194.95%

Maximum Annual PE Ratio = 141.54

Minimum Annual Increase = -768.32%

Minimum Annual PE Ratio = -193.61

Quarterly (TTM)
Annual
YearPE RatioChange
2024-193.61-768.32%
202328.9730.12%
202222.26-7.86%
202124.166.69%
202022.65-52.59%
201947.77137.69%
201820.10-85.80%
2017141.54-188.38%
2016-160.15194.95%
2015-54.3043.69%

Vertex Pharmaceuticals Incorporated (0QZU.L) Average PE Ratio

How has 0QZU.L PE Ratio performed in the past?

The current PE Ratio of Vertex Pharmaceuticals Incorporated (0QZU.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-47.46

5-year avg

-19.11

10-year avg

-10.06

Vertex Pharmaceuticals Incorporated (0QZU.L) PE Ratio vs. Peers

How is 0QZU.L’s PE Ratio compared to its peers?

Vertex Pharmaceuticals Incorporated’s PE Ratio is greater than Regeneron Pharmaceuticals, Inc. (14.15), greater than Teradyne, Inc. (21.97), greater than Skyworks Solutions, Inc. (27.06), greater than Lam Research Corporation (22.75), greater than T. Rowe Price Group, Inc. (10.52),

Build a custom stock screener for Vertex Pharmaceuticals Incorporated (0QZU.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vertex Pharmaceuticals Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vertex Pharmaceuticals Incorporated (0QZU.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vertex Pharmaceuticals Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Vertex Pharmaceuticals Incorporated's PE Ratio?

How is the PE Ratio calculated for Vertex Pharmaceuticals Incorporated (0QZU.L)?

What is the highest PE Ratio for Vertex Pharmaceuticals Incorporated (0QZU.L)?

What is the 3-year average PE Ratio for Vertex Pharmaceuticals Incorporated (0QZU.L)?

What is the 5-year average PE Ratio for Vertex Pharmaceuticals Incorporated (0QZU.L)?

How does the current PE Ratio for Vertex Pharmaceuticals Incorporated (0QZU.L) compare to its historical average?